SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049126
Filing Date
2024-04-26
Accepted
2024-04-26 16:11:14
Documents
4
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A def_proxy_2024.htm DEF 14A 649221
2 GRAPHIC img116409515_0.jpg GRAPHIC 5549
3 GRAPHIC img116409515_1.jpg GRAPHIC 80903
4 GRAPHIC img116409515_2.jpg GRAPHIC 72849
  Complete submission text file 0000950170-24-049126.txt   869459
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39527 | Film No.: 24883810
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)